skip to main content
Idioma:

CoViD vaccines and thrombotic events: EMA issued warning to patients and healthcare professionals

Merchant, Hamid A

Journal of pharmaceutical policy and practice, 2021-03, Vol.14 (1), p.32-32, Article 32 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
  • Título:
    CoViD vaccines and thrombotic events: EMA issued warning to patients and healthcare professionals
  • Autor: Merchant, Hamid A
  • Assuntos: Antibodies ; Blood clots ; Blood platelets ; Coronaviruses ; COVID-19 vaccines ; Medical personnel ; Medical research ; Medicine, Experimental ; Pharmaceutical industry ; Product information ; Protein synthesis ; Proteins ; Severe acute respiratory syndrome coronavirus 2 ; Thrombocytopenia
  • É parte de: Journal of pharmaceutical policy and practice, 2021-03, Vol.14 (1), p.32-32, Article 32
  • Notas: SourceType-Other Sources-1
    content type line 63
    ObjectType-Correspondence-1
  • Descrição: [...]Medicine and Healthcare Regulatory Authority, UK (MHRA) and European Medicines Agency (EMA) initiated a rigorous scientific review of pharmacovigilance data and available evidence to assess the potential association of the vaccine to recent thrombotic events. Medicine and Healthcare Regulatory Authority (MHRA) further stated that sinus vein thrombosis along with thrombocytopenia has been reported in less than one in a million people vaccinated so far in the UK, it can occur naturally and that a causal association with the vaccine could not be established. Nonetheless, genetic vaccines are new, and their long-term safety evaluation is a key to identify potentially contraindicated group of subjects, for instance, patients with history of blood disorders, past or current thrombocytopenia or pre-existing immunological conditions. Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
  • Editor: England: BioMed Central Ltd
  • Idioma: Inglês
Links
Voltar para lista de resultados
Ir para página anteriorAnterior Resultado  9 AvançarIr para próxima página

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.